27433
document
[ Pilot results of using tamsulone-FS in patients with prostatic adenoma according to the results of a randomized multicenter comparative trial ] . Tamsulone-FS -- a novel Russian alpha1A/D-adrenoblocker ( Farm-Syntez ) -- was studied in a randomized multicenter comparative trial in patients with prostatic adenoma . Pilot results agreed with other trials published in the literature and demonstrated tamsulone-FS efficacy and safety for management of lower urinary tract symptoms caused by prostatic adenoma . The efficacy and safety of tamsulone-FS was comparable to those of omnik . This drug can be recommended for wide clinical practice in prostatic adenoma . It is registered by Roszdravnadzor ( certificate N LC-000859 of 03.11.2005 ) and allowed for production and sale .
27434
Intervention_Pharmacological
tamsulone-FS
27435
Intervention_Pharmacological
Tamsulone-FS --
27436
Intervention_Pharmacological
tamsulone-FS
27437
Intervention_Pharmacological
tamsulone-FS
27438
Outcome_Other
efficacy and safety for management of lower urinary tract symptoms
27439
Outcome_Other
The efficacy and safety of tamsulone-FS was comparable to those of omnik .
27440
Outcome_Physical
prostatic adenoma .
27441
Participant_Condition
prostatic adenoma
27442
Participant_Condition
prostatic adenoma